Allergen-induced airway disease is mouse strain dependent

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 285, Issue 1 29-1, 2003, Pages

  Whitehead, Gregory S ^a   Walker, Julia K L ^a   Berman, Katherine G ^a   Foster, W Michael ^a   Schwartz, David A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Airway hyperreactivity; Asthma; Cytokines; Eosinophils

Indexed keywords

ALLERGEN; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 4; OVALBUMIN;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EOSINOPHILIA; INFLAMMATORY DISEASE; LUNG LAVAGE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SENSITIZATION; STRAIN DIFFERENCE; TH2 CELL;

EID: 0038128262     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00390.2002     Document Type: Review

References (48)

1. Brewer JP, Kisselgof AB, and Martin TR. Genetic variability in pulmonary physiological, cellular, and antibody response to antigen in mice. Am J Respir Crit Care Med 160: 1150-1156, 1999.
2. Buchanan DR, Cromwell O, and Kay AB. Neutrophil chemotactic activity in acute severe asthma (status asthmaticus). Am Rev Respir Dis 136: 1397-1402, 1987.
3. Carroll MP, Durham SR, Walsh G, and Kay AB. Activation of neutrophils and monocytes after allergen- and histamine-induced bronchoconstriction. J Allergy Clin Immunol 75: 290-296, 1985.
4. Chiba Y, Yanagisawa R, and Saai M. Strain and route differences in airway responsiveness to acetylcholine in mice. Res Commun Mol Pathol Pharmacol 90: 169-172, 1995.
5. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, and Locksley RM. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 183: 109-117, 1996.
6. De Monchy JG, Kauffman HF, Venge P, Koeter GH, Jansen HM, Sluiter HJ, and De Vries K. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reaction. Am Rev Respir Dis 131: 373-376, 1985.
7. Duff AL and Platt-Mills TA. Allergens and asthma. Pediatr Clin North Am 39: 1277-1291, 1992.
8. European Community Respiratory Health Survey Group. Genes for asthma? An analysis of the European Community Respiratory Health Survey. Am J Respir Crit Care Med 156: 1773-1780, 1997.
9. Fabbri LM, Boschetto P, Zocca E, Milani G, Pivirotto F, Plebani M, Burlina A, Licata B, and Mapp CE. Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate. Am Rev Respir Dis 136: 36-42, 1987.
10. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, and Young IG. Interleukin 5 deficiency abolishes eosinophilia, airway hyperreactivity, and damage in a mouse asthma model. J Exp Med 183: 195-201, 1996.
11. Fukuda T, Fukushima Y, Numao T, Ando N, Arima M, Nakajima H, Sagara H, Adachi T, Motojima S, and Makino S. Role of interleukin-4 and vascular cell adhesion molecule-1 in selective eosinophil migration into the airways in allergic asthma. Am J Respir Cell Mol Biol 14: 84-94, 1996.
12. Gleich GJ. Why do allergic individuals accumulate more eosinophils at the site of an IgE mediated reaction than do normal subjects? Clin Exp Allergy 20: 245-246, 1990.
13. Gray L, Peat JK, Belousova E, Xuan W, and Woolcock AJ. Family patterns of asthma, atopy and airway hyperresponsiveness: an epidemiological study. Clin Exp Allergy 30: 393-399, 2000.
14. Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irwin CG, and Gelfand EW. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 156: 766-775, 1997.
15. Herz U, Braun A, Ruckert R, and Renz H. Various immunological phenotypes are associated with increased airway responsiveness. Clin Exp Allergy 28: 625-634, 1997.
16. Hogan SP, Matthaei KI, Young JM, Koskinen A, Young IG, and Foster PS. A novel T cell-regulated mechanism modulating allergen-induced airway hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J Immunol 161: 1501-1509, 1998.
17. Hogan SP, Mould H, Kikutani H, Ramsay AJ, and Foster PS. Aeroallergen-induced eosinophilic inflammation, lung damage and airway hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobins. J Clin Invest 99: 1329-1339, 1997.
18. Holberg CJ, Morgan WJ, Wright AL, and Martinez FD. Differences in familial segregation of FEV1 between asthmatic and nonasthmatic families. Role of a maternal component. Am J Respir Crit Care Med 158: 162-169, 1999.
19. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, and Barnes PF. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 160: 1532-1539, 1999.
20. Johnston SL, Pattemore PK, Sanderson G, Smith S, Campbell MJ, Josephs LK, Cunningham A, Robinson BS, Myint SH, Ward ME, Tyrell DA, and Holgate ST. The relationship between upper respiratory infections and hospital admission asthma: a time-trend analysis. Am J Respir Crit Care Med 154: 654-660, 1996.
21. Kanehiro A, Lahn M, Makela MJ, Dakhama A, Joetham A, Rha YH, Born W, and Gelfand EW. Requirement for the p75 TNF-α receptor 2 in the regulation of airway hyperresponsiveness by gamma delta T cells. J Immunol 169: 4190-4197, 2002.
22. Kay AB and Durham SR. T-lymphocytes, allergy and asthma. Clin Exp Allergy 21: 17-21, 1991.
23. Kellar KL, Kalwar RR, Dubois KA, Crouse D, Chafin WD, and Kane BE. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry 45: 27-36, 2001.
24. Kips JC and Pauwels RA. The use of knockouts to study determinants of airway hyperresponsiveness. Allergy 54: 903-908, 1999.
25. Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, and Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362: 245-248, 1993.
26. Levitt RC, Mitzner W, and Kleeberger SR. A genetic approach to the study of lung physiology: understanding biological variability in airway responsiveness. Am J Physiol Lung Cell Mol Physiol 258: L157-L164, 1990.
27. Little SA, MacLoad KJ, Chalmers GW, Love JG, McSharry C, and Thomson NC. Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma. Am J Med 112: 446-452, 2002.
28. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, and Vadas MA. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 167: 219-224, 1988.
29. Lorenz E, Jones M, Wohlford-Lenane C, Meyer N, Frees K, Arbour NC, and Schwartz DA. Genes other than TLR-4 are involved in the response to inhaled LPS. Am J Physiol Lung Cell Mol Physiol 281: L1106-L1114, 2001.
30. Los H, Koppelman GH, and Postma DS. The importance of genetic influences in asthma. Eur Respir J 14: 1210-1227, 1999.
31. Louis R, Lau LC, Bron AO, Roldann AC, Radermecker M, and Djukanovic R. The relationship between airway inflammation and asthma severity. Am J Respir Crit Care Med 161: 9-16, 2000.
32. Maddox L and Schwartz DA. The pathophysiology of asthma. Annu Rev Med 53: 477-498, 2002.
33. Milgrom H, Fick RB Jr, Su JQ, Reimann JD, Bush RK, Watrous ML, and Metzger WJ. Treatment of allergic asthma with monoclonal anti-IgE antibody. RhuMAb-E2 study group. N Engl J Med 341: 1966-1973, 1999.
34. Minty A, Asselin S, Bensussan A, Shire D, Vita N, Vyakarnam A, Wijdenes J, Ferrara P, and Caput D. The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes. Eur Cytokine Netw 8: 203-213, 1997.
35. Miyabara Y, Yanagisawa R, Shimojo N, Takano H, Lim HB, Ichinose T, and Sagai M. Murine strain differences in airway inflammation caused by diesel exhaust particles. Eur Respir J 11: 291-298, 1998.
36. Ordonez CL, Shaughnessy TE, Matthay MA, and Fahy JV. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: clinical and biological significance. Am J Respir Crit Care Med 161: 1185-1190, 2000.
37. Sandford A, Weir T, and Pare P. The genetics of asthma. Am J Respir Crit Care Med 153: 1749-1765, 1996.
38. Spry CJ. Mechanism of eosinophilia. VI. Eosinophil mobilization. Cell Tissue Kinet 4: 365-374, 1971.
39. Sybille Y and Reynolds HY. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 141:471-501, 1990.
40. Takeda K, Haczku A, Lee JJ, Irvin CG, and Gelfand EW. Strain dependence of airway hyperresponsiveness reflects differences in eosinophil localization in the lung. Am J Physiol Lung Cell Mol Physiol 281: L394-L402, 2001.
41. Tomkinson A, Kanehiro A, Rabinovitch N, Joetham A, Cieslewicz G, and Gelfand EW. The failure of STAT6-deficient mice to develop airway eosinophilia and airway hyperresponsiveness is overcome by interleukin-5. Am J Respir Crit Care Med 160: 1283-1291, 2001.
42. Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL, and Chu HW. Evidence that severe asthma can be divided pathologically into inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 160: 1001-1008, 1999.
43. Wills-Karp M. The gene encoding interleukin-13: a susceptibility locus for asthma and related traits. Respir Res 1: 19-23, 2000.
44. Wills-Karp M and Ewart SL. The genetics of allergen-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med 156: S89-S96, 1998.
45. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, and Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261, 1998.
46. Woodruff PG and Fahy JV. A role for neutrophils in asthma? Am J Med 112: 498-500, 2002.
47. Yamaguchi Y, Suda T, Suda J, Eguchi M, Miura Y, Harada N, and Tominaga A. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 167: 43-56, 1988.
48. Zhang Y, Lamm WJ, Albert RK, Chi EY, Henderson WR Jr, and Lewis DB. Influence of the route of allergen administration and genetic background on the murine allergic pulmonary response. Am J Respir Crit Care Med 155: 661-669, 1997.